Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3428]
News [7862]
Articles [63]
Editorials [9]
Conferences [212]
elearning [49]
Survival analysis of newly diagnosed transplant-eligible multiple myeloma...
Dr Francesca Gay - University of Torino, Torino, Italy
Survival analysis of newly diagnosed transplant-eligible multiple myeloma patients in the randomised Forte trial ( Dr Francesca Gay - University of Torino, Torino, Italy )
14 Dec 2020
Latest data for managing ALK NSCLC patients
Prof Myung-Ju Ahn - Samsung Medical Center, Seoul, South Korea
Latest data for managing ALK NSCLC patients ( Prof Myung-Ju Ahn - Samsung Medical Center, Seoul, South Korea )
11 Dec 2020
Clinical activity and safety of cevostamab in relapsed/refractory multiple...
Prof Adam Cohen - University of Pennsylvania, Philadelphia, USA
Clinical activity and safety of cevostamab in relapsed/refractory multiple myeloma ( Prof Adam Cohen - University of Pennsylvania, Philadelphia, USA )
10 Dec 2020
ASCEMBL: Asciminib for hard-to-treat chronic myeloid leukaemia
Prof Andreas Hochhaus - Universitätsklinikum Jena, Jena, Germany
ASCEMBL: Asciminib for hard-to-treat chronic myeloid leukaemia ( Prof Andreas Hochhaus - Universitätsklinikum Jena, Jena, Germany )
10 Dec 2020
Inotuzumab ozogamicin in paediatric CD22-positive r/r acute lymphoblastic...
Dr Erica Brivio - Princess Máxima Center for Pediatric Oncology, Utrecht...
Inotuzumab ozogamicin in paediatric CD22-positive r/r acute lymphoblastic leukaemia: results of the ITCC-059 study ( Dr Erica Brivio - Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands )
9 Dec 2020
OncoAlert and ecancer weekly roundup for November 22 - Dec 5, 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for November 22 - Dec 5, 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
9 Dec 2020
Novel bispecific T-cell engager molecule shows promise in r/r multiple myeloma
Prof Simon Harrison - Peter MacCallum Cancer Centre, Melbourne, Australia
Novel bispecific T-cell engager molecule shows promise in r/r multiple myeloma ( Prof Simon Harrison - Peter MacCallum Cancer Centre, Melbourne, Australia )
9 Dec 2020
Analysis of the B-HOLISTIC study and importance of relapsed/refractory Hodgkin...
Prof Mark Hertzberg - Prince of Wales Hospital, Sydney, Australia
Analysis of the B-HOLISTIC study and importance of relapsed/refractory Hodgkin lymphoma real world evidence data ( Prof Mark Hertzberg - Prince of Wales Hospital, Sydney, Australia )
8 Dec 2020
Five year update of ECHELON-1 for classical Hodgkin lymphoma
Dr Otavio Baiocchi - Centro Especializado em Oncologia, São Paulo, Brazil
Five year update of ECHELON-1 for classical Hodgkin lymphoma ( Dr Otavio Baiocchi - Centro Especializado em Oncologia, São Paulo, Brazil )
8 Dec 2020
Real world management of multiple myeloma patients
Dr Patricio Duarte - Instituto Universitario CEMIC, Buenos Aires, Argentina
Real world management of multiple myeloma patients ( Dr Patricio Duarte - Instituto Universitario CEMIC, Buenos Aires, Argentina )
8 Dec 2020
ZUMA-12: Axicabtagene ciloleucel for high-risk large B cell lymphoma
Prof Sattva Neelapu - MD Anderson Cancer Center, Houston, USA
ZUMA-12: Axicabtagene ciloleucel for high-risk large B cell lymphoma ( Prof Sattva Neelapu - MD Anderson Cancer Center, Houston, USA )
7 Dec 2020
Ibrutinib plus venetoclax for first-line treatment of chronic lymphocytic...
Dr William Wierda - University of Texas MD Anderson Cancer Center, Houston, USA
Ibrutinib plus venetoclax for first-line treatment of chronic lymphocytic leukaemia ( Dr William Wierda - University of Texas MD Anderson Cancer Center, Houston, USA )
5 Dec 2020

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation